美單日新增8.9萬宗新冠確診 料周內準第三劑疫苗擴至所有成年人
阿思達克 11-17 16:07
美國新冠疫情見反彈跡象。據美國約翰霍普金斯大學統計，截至美國西岸時間午夜(本港時間下午4時)，美國累計新冠確診47,311,015宗，單日新增89,368宗。累計死亡個案765,913宗，單日新增1,548宗。
美媒報道，美國食品及藥物管理局料將在週四(18日)批準向所有成年人接種第三劑「復必泰」，接種者須在半年前完成接種「復必泰」或Moderna疫苗，或在兩個月前完成接種強生疫苗。美國疾控中心轄下專家組計劃週五(19日)開會，討論允許所有成年人接種第三劑新冠疫苗，中心料在會後短時間內正式作出建議，意味第三劑疫苗接種計劃可擴至全美成年人。有關小組早前已批準爲長者及高危羣組，包括長期病患及於高度風險環境下居住或工作人士接種第三劑「復必泰」。
據美媒統計，美國有31個州份新冠確診個案上升，截至週一(15日)一週累計確診584,449宗，較截至上月26日一週的低位增加15%。
以下爲美國過去八天每日新冠疫情統計：
日期│累計確診│單日新增確診│累計死亡│單日新增死亡
11月16日(二)│47,311,015宗│+ 89,368宗│765,913宗│+1,548宗
11月15日(一)│47,221,647宗│+147,567宗│764,365宗│+1,273宗
11月14日(日)│47,074,080宗│+ 22,650宗│763,092宗│+ 120宗
11月13日(六)│47,051,430宗│+ 60,093宗│762,972宗│+ 451宗
11月12日(五)│46,991,337宗│+138,541宗│762,521宗│+2,844宗
11月11日(四)│46,852,796宗│+ 60,715宗│759,677宗│+ 617宗
11月10日(三)│46,792,081宗│+ 97,290宗│759,060宗│+1,654宗
11月 9日(二)│46,694,791宗│+ 81,581宗│757,406宗│+1,763宗
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
More Content
CS Hotline: +852 3018 4526
Trading days: 24 hours | Non-trading days: 9:00-18:00
